Connection
Paul Awolade to Neoplasms
This is a "connection" page, showing publications Paul Awolade has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.105 |
|
|
|
-
Clune S, Awolade P, Zhou Q, Esquer H, Matter B, Kearns JT, Kellett T, Akintayo DC, Kompella UB, LaBarbera DV. The validation of new CHD1L inhibitors as a therapeutic strategy for cancer. Biomed Pharmacother. 2024 Jan; 170:116037.
Score: 0.086
-
Kumar V, Dhawan S, Girase PS, Awolade P, Shinde SR, Karpoormath R, Singh P. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective. Curr Med Chem. 2021 Oct 25; 28(33):6805-6845.
Score: 0.019